China Vaccine Industry Report, 2008-2009

Publication Date	August 2009
Publisher	Research in China
Product Type	Report
Pages	77
ISBN Number	not applicable
Product Code	RIC00544

Buy this product or for assistance call +44 20 7060 7474

PDF £900.00$1497 | €1007

PRINT £870.00$1447 | €974

FAX Order above formats by FAX

Summary

In the past decade, Chinese vaccine market tripled in scale. China has already become the world's largest vaccine producer and now has 28 vaccine companies, ranking NO.1 around the globe. It can produce one billion person-portions annually, besides, varieties and quantity also ranks the top in the world.

Output of common vaccine reaches 500 million person-portions such as HBV vaccine, measles vaccine, etc. Fully planned immunization has been realized.

Compared to developed countries, expenses of China on vaccine and diseases treatment are relatively low; therefore, China will attach great importance to vaccine industry development and take it as the key of healthcare and bio-technology industry. The Development Strategy of China Bio-technology Industry has rendered the development of secure new types of vaccines as priority; in the meantime, Chinese government has employed preferential taxation policy to this industry. In consequence, vaccine industry will become a high-tech sector with great potential in China bio-technology field. It is forecasted that China vaccine market scale will approximate RMB8 billion in 2020, with an annual growth rate of 15%, far above world's level 10%.

Based on authoritative statistics, this report makes in-depth analysis on China vaccine industry development, vaccine market, vaccine import & export, key vaccine producers, and also forecasts the development trend of China's vaccine industry in 2009. Vaccines involved in this report are Flu Vaccine, HBV Vaccine, Cerebrospinal Meningitis Vaccine, HIV vaccine, A/HINI vaccine as well as anima vaccines.

Content

1. Overview of China Vaccine Market
- 1.1 Impact of Globalization on China Pharmaceutical Market
  - 1.1.1 Pharmaceutical Industry Restructuring and International Division of Labor
  - 1.1.2 Accelerated Globalization of Pharmaceutical Market
  - 1.1.3 International Status of China Pharmaceutical Industry
  - 1.1.4 Forecast of China Status in Global Pharmaceutical Industry, 2009
- 1.2 Strategies for the Access into China Vaccine Market
  - 1.2.1 Policy on Foreign Capital Entry into China Vaccine Market
  - 1.2.2 Competition Strategies of Chinese Vaccine Companies
  - 1.2.3 China Vaccine Market Position in the Global Market
- 1.3 China Biopharmaceutical Sector
  - 1.3.1 Sales Revenue, 2008
  - 1.3.2 Total production Value, 2008
  - 1.3.3 Development Trend, 2009
2. China Vaccine Market Development in 2008-2009
- 2.1 Market Characteristics, 2008
- 2.2 Main Vaccines Types, 2008
- 2.3 Market Structure, 2008
- 2.4 Market Characteristics, 2008
- 2.5 Market Tendency, 2008
- 2.6 Suggestions for Vaccine Industry Development, 2008
3. Markets of Vaccine Varieties, 2008
- 3.1 China Flu Vaccine Market, 2008
  - 3.1.1 Market Background
  - 3.1.2 Technology R&D
  - 3.1.3 Market Size
  - 3.1.4 Competition
  - 3.1.5 Market Demand
  - 3.1.6 Key Producers
- 3.2 China HBV Vaccine Market
  - 3.2.1 Market Background
  - 3.2.2 Market Size
  - 3.2.3 Main Products
- 3.3 China MCV Vaccine Market
  - 3.3.1 Market Background
  - 3.3.2 Market Size
- 3.4 China AIDS Vaccine Market
  - 3.4.1 Market Background
  - 3.4.2 Market Size
  - 3.4.3 R & D
- 3.5 Other Vaccine Markets and R & D
  - 3.5.1 Lung Cancer Vaccine
  - 3.5.2 Measles Vaccine
  - 3.5.3 Cervical Cancer Vaccine
  - 3.5.4 Lupus Erythematosus Vaccine
  - 3.5.5 Rotavirus Vaccine
  - 3.5.6 Tumor Vaccine
  - 3.5.7 A H1N1 Vaccine
4. China Animal Vaccine Market, 2008
- 4.1 Basis of Demand
  - 4.1.1 Green Barriers: Promotion of Animal Vaccine
  - 4.1.2 Market Background of and Demand for Pet Vaccine
- 4.2 Research Progress in Vaccine for Animal
  - 4.2.1 R&D of Animal Virus Vaccine
  - 4.2.2 Animal Vaccine R&D Bases in China
  - 4.2.3 Successful Development of Purified Rabies Vaccine for Human
  - 4.2.4 Research Progress in Pseudorabies Gene-deleted Vaccine
- 4.3 China Bird Flue Vaccine Market
  - 4.3.1 Market Background
  - 4.3.2 Key Producers
- 4.4 Competition Layout of China Animal Vaccine Market
5. Import and Export of China Vaccine
- 5.1 General Trend of Vaccine Trade
- 5.2 Comparison between Imported Vaccine and Homemade Vaccine
6. China Key Vaccine Producers
- 6.1 China National Biotech Group Co., Ltd
- 6.2 Beijing Tiantan Biological Products Co., Ltd
- 6.3 Shanghai Institute of Biological Products
- 6.4 Shenzhen Kangtai Biological Products Co., Ltd
- 6.5 Changchun Changsheng Life Sciences Co., Ltd
- 6.6 Shenzhen Neptunus Bioengineering Co., Ltd
- 6.7 Guangxi Beisheng Pharmaceutical Co., Ltd
- 6.8 Star Lake Bioscience Co., Ltd
- 6.9 Shanghai Fosun Pharmaceutical (Group) Co., Ltd
- 6.10 Jiangsu Sihuan Bioengineering Co., Ltd
- 6.11 Northeast Pharmaceutical Group Co., Ltd
- 6.12 Chengdu Hoist Group Co., Ltd
- 6.13 Hualan Biological Engineering Inc.
- 6.14 China National Agricultural Development Group Corporation
- 6.15 Zhejiang Huahai Pharmaceutical Co., Ltd
7. Impact of SARS on Vaccine Market
- 7.1 Vaccine Market Activated by SARS
  - 7.1.1 Booming of Vaccine Industry
  - 7.1.2 Bottleneck of Vaccine Industry
  - 7.1.3 R&D of SARS Vaccine
- 7.2 Dispute of SARS Patent and Market
- 7.3 Patent Protection Measures on Anti SARS Vaccine
8. Vaccine Market Development Trend and Forecast, 2009
- 8.1 Latest Information on Vaccine R&D
  - 8.1.1 Development Trend of New Types of Vaccines
  - 8.1.2 New Types of Vaccines
  - 8.1.3 R&D of New Types of Vaccines
  - 8.1.4 New Types of Combined Vaccines
- 8.2 Forecast of Vaccine Market, 2009
  - 8.2.1 Forecast of Global Various Vaccines Markets, 2009
  - 8.2.2 Forecast of Animal Vaccine Sector